EG vs VRDN · P/E 17, rev $8.03B vs rev $425.0K
Everest Group Ltd (EG) versus Viridian Therapeutics Inc (VRDN) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
EG currently screens at market cap $14.52B and trailing P/E 17.2. VRDN currently screens at market cap $1.39B.
Not investment advice. Open the EG and VRDN stock pages for the full models.
Not investment advice.